Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP869901.RAHBHF4N1H0B4-2ZM0G_FwJKp-8MGoZWbOLKc-ScC661I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP869901.RAHBHF4N1H0B4-2ZM0G_FwJKp-8MGoZWbOLKc-ScC661I130_assertion type Assertion NP869901.RAHBHF4N1H0B4-2ZM0G_FwJKp-8MGoZWbOLKc-ScC661I130_head.
- NP869901.RAHBHF4N1H0B4-2ZM0G_FwJKp-8MGoZWbOLKc-ScC661I130_assertion description "[The isoform as detected byanti-IL-17RC intracellular domain antibodies (anti-ICD) was expressed at higher levels in androgen-independent prostate cancer cell lines (PC3 and DU145) than in androgen-dependent prostatic cell lines (RWPE-1, pRNS-1-1, MLC-SV40, and LNCaP).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869901.RAHBHF4N1H0B4-2ZM0G_FwJKp-8MGoZWbOLKc-ScC661I130_provenance.
- NP869901.RAHBHF4N1H0B4-2ZM0G_FwJKp-8MGoZWbOLKc-ScC661I130_assertion evidence source_evidence_literature NP869901.RAHBHF4N1H0B4-2ZM0G_FwJKp-8MGoZWbOLKc-ScC661I130_provenance.
- NP869901.RAHBHF4N1H0B4-2ZM0G_FwJKp-8MGoZWbOLKc-ScC661I130_assertion SIO_000772 17603628 NP869901.RAHBHF4N1H0B4-2ZM0G_FwJKp-8MGoZWbOLKc-ScC661I130_provenance.
- NP869901.RAHBHF4N1H0B4-2ZM0G_FwJKp-8MGoZWbOLKc-ScC661I130_assertion wasDerivedFrom befree-20150227 NP869901.RAHBHF4N1H0B4-2ZM0G_FwJKp-8MGoZWbOLKc-ScC661I130_provenance.
- NP869901.RAHBHF4N1H0B4-2ZM0G_FwJKp-8MGoZWbOLKc-ScC661I130_assertion wasGeneratedBy ECO_0000203 NP869901.RAHBHF4N1H0B4-2ZM0G_FwJKp-8MGoZWbOLKc-ScC661I130_provenance.